Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data

被引：0
|
作者：
Sanjiv Kapoor
Viswanath V. Kaushik
Rahul Jain
Vijay Rao
Mihir Gharia
机构：
[1] Indian Spinal Injuries Centre,Rheumatology
[2] Arthritis & Rheumatism Centre,Medical Affairs, Zydus Biovation
[3] Narayana Multispeciality Hospital,undefined
[4] Manipal Hospital,undefined
[5] Cadila Healthcare Ltd,undefined
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
Adalimumab; Biosimilar; Real-life; Registry; Rheumatoid Arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：451 / 459
页数：8
相关论文
共 50 条
  • [1] Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
    Kapoor, Sanjiv
    Kaushik, Viswanath V.
    Jain, Rahul
    Rao, Vijay
    Gharia, Mihir
    [J]. RHEUMATOLOGY AND THERAPY, 2019, 6 (03) : 451 - 459
  • [2] Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
    Kapoor, Sanjiv
    Kaushik, Viswanath V.
    Jain, Rahul
    Rao, Vijay K. R.
    Gharia, Mihir
    [J]. ACR OPEN RHEUMATOLOGY, 2019, 1 (08) : 480 - 484
  • [3] ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFECTIVE AS ADALIMUMAB AND INFLIXIMAB IN A COHORT OF REAL-LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Saavedra-Martinez, G.
    Villarreal, L.
    Gomez, D.
    Bello-Gualtero, J.
    Giraldo, V.
    Martinez, P.
    Sanchez, A.
    Sanchez, M.
    Uribe, E.
    Boon, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 790
  • [4] Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data
    Atzeni, Fabiola
    Gerratana, Elisabetta
    Bongiovanni, Sara
    Talotta, Rossella
    Miceli, Gianfranco
    Salaffi, Fausto
    Sarzi-Puttini, Piercarlo
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (06): : 344 - 349
  • [5] The Safety and Effectiveness of Infliximab Biosimilar in Managing Rheumatoid Arthritis: A Real-Life Experience from Jordan
    Alawneh, Khaldoon
    Al-Mistarehi, Abdel-Hameed
    Qandeel, Ali
    Jaber, Ruba
    Alomari, Safwan
    Kheirallah, Khalid A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [6] DISCONTINUATION AND EFFECTIVENESS OF ORIGINATOR AND BIOSIMILAR TNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS: REAL WORLD DATA FROM A RHEUMATOID ARTHRITIS REGISTRY IN CANADA
    Movahedi, M.
    Cesta, A.
    Li, X.
    Bombardier, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1381 - 1381
  • [7] Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
    Sizheng Zhao
    Laura Chadwick
    Eduardo Mysler
    Robert J. Moots
    [J]. Current Rheumatology Reports, 2018, 20
  • [8] Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
    Zhao, Sizheng
    Chadwick, Laura
    Mysler, Eduardo
    Moots, Robert J.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [9] COMPARATIVE EFFECTIVENESS ABATACEPT, ADALIMUMAB AND RITUXIMAB IN PATIENTS WITH LONG-STANDING RHEUMATOID ARTHRITIS IN A REAL-LIFE SETTING
    Santos-Moreno, P.
    Villarreal, L.
    Ballesteros, G.
    Bello, J.
    Castillo, E.
    Giraldo, R.
    Gomez, D.
    Aza, A.
    Lopez, A.
    Cardozo, A.
    Palacio, N.
    Castro, C.
    Buitrago-Garcia, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1030 - 1030
  • [10] Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
    D'Angelo, Salvatore
    Cantini, Fabrizio
    Ramonda, Roberta
    Cantarini, Luca
    Carletto, Antonio
    Chimenti, Maria Sole
    Delle Sedie, Andrea
    Foti, Rosario
    Gerli, Roberto
    Lomater, Claudia
    Lubrano, Ennio
    Marchesoni, Antonio
    Zabotti, Alen
    Salvarani, Carlo
    Scrivo, Rossana
    Scarpa, Raffaele
    Tramontano, Giuseppina
    Nannini, Carlotta
    Lorenzin, Mariagrazia
    Fabbroni, Marta
    Martinis, Federica
    Perricone, Roberto
    Carli, Linda
    Visalli, Elisa
    Rovera, Guido
    Perrotta, Fabio Massimo
    Quartuccio, Luca
    Altobelli, Alessio
    Costa, Luisa
    Niccoli, Laura
    Ortolan, Augusta
    Caso, Francesco
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
12345